Sequence Similarity Clusters for the Entities in PDB 1MCQ

Entity #1 | Chains: A,B
IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 15 19 1355
95 % 15 20 1550 Flexibility: Medium
Max RMSD: 14.5, Avg RMSD: 7.2
PDBFlex
90 % 55 86 257
70 % 1581 2660 1
50 % 3229 5401 1
40 % 3673 6098 1
30 % 4509 7565 1
Entity #2 | Chains: P
PEPTIDE N-ACETYL-L-HIS-D-PRO-NH2 protein, length: 4 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
29 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
30 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
31 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
32 4XCF 1 L 4E10 Fab light chain 9606
33 4XCF 2 H 4E10 Fab heavy chain 9606
34 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
35 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
36 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
37 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
38 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
39 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
40 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
41 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
42 5X08 1 H Fab 4E10 Heavy chain 9606
43 5X08 2 L Fab 4E10 Light chain 9606
44 4XAW 1 L 4E10 Fab light chain 9606
45 4XAW 2 H 4E10 Fab heavy chain 9606
46 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
47 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
48 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
49 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
50 5UCB 1 H Fab Heavy Chain 9606
51 5UCB 2 L Fab Light Chain 9606
52 2VXV 1 H HUMAN IGG ABT-325 9606
53 2VXV 2 L HUMAN IGG ABT-325 9606
54 4GXV 1 H, I Antibody 1F1, heavy chain 9606
55 4GXV 2 L, M Antibody 1F1, light chain 9606
56 2VXT 1 H MURINE IGG 125-2H 10090
57 2VXT 3 L MURINE IGG 125-2H 10090
58 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
59 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
60 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
61 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
62 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
63 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
64 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
65 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
66 5W24 1 L 5C4 Fab Light Chain 10090
67 5W24 2 H 5C4 Fab Heavy Chain 10090
68 4HPY 1 H CH59 Fab heavy chain 9606
69 4HPY 2 L CH59 Fab light chain 9606
70 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
71 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
72 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
73 4JG1 1 L Fab light chain 9606
74 4JG1 2 H Fab heavy chain 9606
75 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
76 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
77 5VF2 1 A scFv 2D10 10090
78 5I8C 1 A VRC34.01 Fab heavy chain 9606
79 5I8C 2 B VRC34.01 Fab light chain 9606
80 4O5L 1 L Fab F045-092 light chain 9606
81 4O5L 2 H Fab F045-092 heavy chain 9606
82 5MYX 1 A, C Fab c#24 light chain 10090
83 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
84 3IFL 1 L 12A11 FAB antibody light chain 10090
85 3IFL 2 H 12A11 FAB antibody heavy chain 10090
86 5WK2 1 L M116 LIGHT CHAIN 9606
87 5WK2 2 H M116 HEAVY CHAIN FD 9606
88 3PP4 1 H GA101 Fab heavy chain 10090
89 3PP4 2 L GA101 Fab light chain 10090
90 3KDM 1 A, L Immunoglobulin light chain 9606
91 3KDM 2 B, H Immunoglobulin heavy chain 9606
92 5NIV 1 A Light chain of 5D3 Fab 10090
93 5NIV 2 B Heavy chain of 5D3 Fab 10090
94 5N4J 1 L LIGHT CHAIN 9606
95 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
96 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
97 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
98 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
99 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
100 5X4G 1 A 6H8 Fab heavy chain 10090
101 5X4G 2 B 6H8 Fab light chain 10090
102 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
103 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
104 4PTU 1 A Antibody pn132p2C05, light chain 9606
105 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
106 4TPR 1 L If kappa light chain 10090
107 4TPR 2 H Fab heavy chain 10090
108 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
109 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
110 3IFN 1 H 12A11 FAB antibody heavy chain 10090
111 3IFN 2 L 12A11 FAB antibody light chain 10090
112 5U3P 1 H DH511.4 Fab Heavy Chain 9606
113 5U3P 2 L DH511.4 Fab Light Chain 9606
114 6BLA 1 H AMM01 Fab Heavy chain 9606
115 6BLA 2 L AMM01 Fab Light chain 9606
116 4TOY 1 H 35O22 Fab Heavy chain 9606
117 4TOY 2 L 35O22 Fab Light chain 9606
118 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
119 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
120 3NPS 2 B S4 FAB HEAVY CHAIN 9606
121 3NPS 3 C S4 FAB LIGHT CHAIN 9606
122 5I4F 1 A scFv 2D10 10090
123 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
124 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
125 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
126 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
127 5WN9 1 H scFv 2D10 9606
128 4XC3 1 L 4E10 Fab light chain 9606
129 4XC3 2 H 4E10 Fab heavy chain 9606
130 4M5Y 1 H, I Fab 5J8 heavy chain 9606
131 4M5Y 2 L, M Fab 5J8 light chain 9606
132 4TQE 1 L If kappa light chain 10090
133 4TQE 2 H Fab heavy chain 10090
134 5YY4 1 A scFv 4B08 10090
135 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
136 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
137 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
138 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
139 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
140 5VSI 2 L CH1/Ckappa Fab light chain 9606
141 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
142 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
143 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
144 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
145 5JXA 1 H VRC03 Heavy chain 9606
146 5JXA 2 L VRC03 Light chain 9606
147 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
148 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
149 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
150 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
151 3NTC 1 L Fab light chain 10090
152 3NTC 2 H Fab heavy chain 10090
153 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
154 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
155 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
156 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
157 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
158 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
159 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
160 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
161 6BE3 1 H Fab (F598) Heavy Chain 9606
162 6BE3 2 L Fab (F598) Light Chain 9606
163 4NWU 1 H APE1551 Ab Fab heavy chain 9606
164 4NWU 2 L APE1551 Ab Fab light chain 9606
165 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
166 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
167 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
168 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
169 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
170 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
171 5EWI 1 H VRC38.01 Heavy Chain 9606
172 5EWI 2 L VRC38.01 Light Chain 9606
173 5E2W 1 L AT8 LIGHT CHAIN 10090
174 5E2W 2 H AT8 HEAVY CHAIN 10090
175 5MYK 1 A Fab c#17 light chain 10090
176 5MYK 2 B Fab c#17 heavy chain 10090
177 4NZR 1 H PGT135 heavy chain Fab 9606
178 4NZR 2 L PGT135 light chain Fab 9606
179 5MYO 1 A, C Fab c#6 light chain 10090
180 5MYO 2 B, D Fab c#6 heavy chain 10090
181 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
182 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
183 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
184 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
185 5UEL 1 H 354NC102 Fab Heavy Chain 9606
186 5UEL 2 L 354NC102 Fab Light Chain 9606
187 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
188 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
189 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
190 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
191 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
192 5E2V 1 L AT8 LIGHT CHAIN 10090
193 5E2V 2 H AT8 HEAVY CHAIN 10090
194 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
195 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
196 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
197 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
198 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
199 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
200 5JUE 1 L light chain of UIC2 Fab 10090
201 5JUE 2 H heavy chain of UIC2 Fab 10090
202 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
203 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
204 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
205 5JR1 1 H 10E8 heavy chain 9606
206 5JR1 2 L 10E8 mature light chain 9606
207 6CA7 1 L PCT64_13C light chain 9606
208 6CA7 2 H PCT64_13C heavy chain 9606
209 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
210 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
211 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
212 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
213 5OB5 2 H fAb Heavy chain 9606
214 5OB5 3 L fAb Light chain 9606
215 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
216 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
217 5I66 1 A 8B6 antibody, heavy chain 10090
218 5I66 2 B 8B6 antibody, light chain 10090
219 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
220 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
221 6BZY 1 H 22D11 Heavy Chain 10090
222 6BZY 2 L 22D11 Light Chain 10090
223 3QQ9 1 C, L 101F LIGHT CHAIN 10090
224 3QQ9 2 D, H 101F HEAVY CHAIN 10090
225 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
226 5TKK 3 L mouse antibody vFP5.01 light chain 10090
227 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
228 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
229 5W6C 1 H UCA Fab heavy chain 9606
230 5W6C 2 L UCA Fab light chain 9606
231 5I1K 1 L FAB LIGHT CHAIN 9606
232 5I1K 2 H FAB HEAVY CHAIN 9606
233 3OZ9 1 L Fab NC-1 kappa light chain 10090
234 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
235 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
236 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
237 5V7U 1 L CBTAU-22.1 Fab light chain 9606
238 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
239 5UEA 1 A, H Fab Heavy Chain 9606
240 5UEA 3 B, L Fab Light Chain 9606
241 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
242 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
243 3G5Y 1 A 175 light chain 10090
244 3G5Y 2 B 175 heavy chain 10090
245 5NMV 1 L Fab light chain 10088
246 5NMV 2 H Fab heavy chain 10088
247 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
248 4N8C 2 L, M Light chain of monoclonal antibody 10090
249 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
250 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
251 4HGW 1 A Antibody Fab fragment, light chain 10090
252 4HGW 2 B Antibody Fab fragment, heavy chain 10090
253 1NLB 1 L antibody 19D9D6 light chain 10090
254 1NLB 2 H antibody 19D9D6 heavy chain 10090
255 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
256 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
257 3VFG 1 L 3F8 Light Chain 10090
258 3VFG 2 H 3F8 Heavy Chain 10090
259 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
260 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
261 3QRG 1 L Fab light chain 9606
262 3QRG 2 H Fab heavy chain Fd fragment 9606
263 5M6A 1 A, B, C, D Bence-Jones light chain 9606
264 4LLY 2 B, D light chain Clambda 9606
265 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
266 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
267 5EZI 1 H Fab c12 heavy chain 9606
268 5EZI 2 L Fab c12 Light chain 9606
269 4K23 1 H anti-uPAR antibody, heavy chain 10090
270 4K23 2 L anti-uPAR antibody, light chain 10090
271 3NCJ 1 L Fab15 Mut8 light chain 9606
272 3NCJ 2 H Fab15 Mut8 heavy chain 9606
273 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
274 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
275 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
276 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
277 5W05 1 L M59 FAB LIGHT CHAIN 10090
278 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
279 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
280 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
281 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
282 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
283 4M61 1 A, C Fab A52 light chain 10090
284 4M61 2 B, D Fab A52 heavy chain 10090
285 5YE3 1 B 2A7D9 VH CH1 chain 10090
286 5YE3 2 A 2A7D9 L chain 10090
287 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
288 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
289 1UM5 1 L Antibody 21H3 L chain 10090
290 1UM5 2 H Antibody 21H3 H chain 10090
291 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
292 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
293 4NWT 1 L APE1531 Ab Fab light chain 9606
294 4NWT 2 H APE1531 Ab Fab heavy chain 9606
295 3WHX 1 A mAb Fab H fragment 10090
296 3WHX 2 B mAb Fab L fragment 10090
297 3NA9 1 L Fab15 light chain 9606
298 3NA9 2 H Fab15 heavy chain 9606
299 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
300 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
301 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
302 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
303 4LRI 1 A, B MSL-109 Light Chain 9606
304 4LRI 2 C, P MSL-109 Heavy Chain 9606
305 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
306 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
307 4JN2 1 A, L anti dabigatran Fab 10090
308 4JN2 2 B, H anti dabigatran Fab 10090
309 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
310 4XBE 2 H 4E10 Fab heavy chain 9606
311 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
312 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
313 6BE2 1 H Fab (F598) Heavy Chain 9606
314 6BE2 2 L Fab (F598) Light Chain 9606
315 4JFZ 1 L Fab light chain 9606
316 4JFZ 2 H Fab heavy chain 9606
317 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
318 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
319 3WIF 1 A mAb Fab H fragment 10090
320 3WIF 2 B mAb Fab L fragment 10090
321 5U6A 1 A Light Chain 9606
322 5U6A 2 B Heavy Chain 9606
323 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
324 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
325 3MBX 1 L X836 LIGHT CHAIN 10090
326 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
327 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
328 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
329 6APC 1 H Epididymis luminal protein 214 9606
330 6APC 2 L IGL@ protein 9606
331 4HHA 1 A Fab KE5 Fab fragment KE5 9606
332 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
333 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
334 4RGO 2 H 14G8 heavy chain Fab 10090
335 4RGO 3 L 14G8 light chain Fab 10090
336 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
337 5GRY 1 A, G diabody 9606
338 5UEK 2 H Fab 12E Heavy Chain 9606
339 5UEK 3 L Fab 12E Light Chain 9606
340 3NAA 1 L Fab15 Mut5 light chain 9606
341 3NAA 2 H Fab15 Mut5 heavy chain 9606
342 1Q0X 1 L Fab 9B1, light chain 10090
343 1Q0X 2 H Fab 9B1, heavy chain 10090
344 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
345 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
346 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
347 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
348 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
349 5IK3 2 B, D 1E03 Fab fragment light chain 9606
350 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
351 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
352 5XLI 1 a, b FabL 10090
353 5XLI 2 c, d FabH 10090
354 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
355 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
356 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
357 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
358 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
359 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
360 4WUK 1 H CH65 heavy chain 9606
361 4WUK 2 L CH65 light chain 9606
362 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
363 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
364 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
365 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
366 5JOP 1 D, L Fab 14.22 light chain 10090
367 5JOP 2 E, H Fab14.22 heavy chain 10090
368 4HPO 1 H CH58 Fab heavy chain 9606
369 4HPO 2 L CH58 Fab light chain 9606
370 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
371 5UKN 2 L DH522UCA Fab fragment light chain 9544
372 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
373 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
374 5IT2 1 H heavy chain 9606
375 5IT2 2 L light chain 9606
376 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
377 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
378 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
379 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
380 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
381 5MO3 3 L Fab of monoclonal antibody, light chain 10090
382 5GZ0 1 A, C FM329 light chain 1383439
383 5GZ0 2 B, D FM329 heavy chain 1383439
384 6DW2 1 A 6078 Fab light chain 9606
385 6DW2 2 B 6078 Fab heavy chain 9606
386 6BQB 1 L MGG4 Fab light chain 9606
387 6BQB 2 H MGG4 Fab heavy chain 9606
388 4PUB 1 H DX-2930 HEAVY CHAIN 9606
389 4PUB 2 L DX-2930 LIGHT CHAIN 9606
390 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
391 6B14 2 L Light chain of Fab BL3-6S97N 10090
392 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
393 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
394 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
395 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
396 5GS3 1 A, H diabody protein 9606
397 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
398 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
399 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
400 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
401 5VKD 2 H Fab Heavy Chain 9606
402 5VKD 3 L Fab light chain 9606
403 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
404 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
405 5XHG 1 A, C polypeptide(L) 10090
406 5XHG 2 B, D polypeptide(H) 10090
407 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
408 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
409 3UYR 1 H antibody Fab heavy chain 10090
410 3UYR 2 L antibody Fab light chain 10090
411 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
412 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
413 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
414 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
415 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
416 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
417 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
418 3OAZ 2 K, L Fab 2G12, light chain 9606
419 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
420 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
421 1ZAN 1 L Fab AD11 Light Chain 10116
422 1ZAN 2 H Fab AD11 Heavy Chain 10116
423 6CJK 1 A, C Immunoglobulin Fab light chain 9986
424 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
425 4N0Y 1 H IGH526 Heavy Chain 9606
426 4N0Y 2 L IGH526 Light Chain 9606
427 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
428 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
429 5MTH 1 A, H antibody Fab heavy chain 10090
430 5MTH 2 B, L antibody Fab light chain 10090
431 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
432 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
433 1RZF 1 L Fab E51 light chain 9606
434 1RZF 2 H Fab E51 heavy chain 9606
435 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
436 4KTE 2 L GE148 Light Chain Fab 9544
437 5I8O 1 H HMM5 antibody heavy chain 9606
438 5I8O 2 L HMM5 antibody light chain 9606
439 4JG0 1 L Fab light chain 9606
440 4JG0 2 H Fab heavy chain 9606
441 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
442 4YGV 2 B, L aDabi-Fab2a light chain 9606
443 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
444 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
445 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
446 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
447 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
448 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
449 3EO0 1 A, C GC-1008 Fab Light Chain 10090
450 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
451 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
452 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
453 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
454 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
455 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
456 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
457 4FQI 3 H antibody CR9114 heavy chain Fab 9606
458 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
459 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
460 4JHA 2 L D25 light chain 9606
461 6B9Z 1 A Trastuzumab Fab light chain 10090
462 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
463 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
464 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
465 4PTT 1 A Antibody pn132p2C05, light chain 9606
466 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
467 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
468 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
469 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
470 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
471 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
472 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
473 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
474 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
475 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
476 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
477 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
478 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
479 4DGV 1 H HCV1 Heavy Chain Fab 9606
480 4DGV 2 L HCV1 Light Chain 9606
481 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
482 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
483 5TH2 1 A, C cetuximab Fab, light chain 10090
484 5TH2 2 B, D cetuximab Fab, heavy chain 10090
485 5I8K 1 L HHH1 Fab Light chain 9606
486 5I8K 2 H HHH1 Fab Heavy chain 9606
487 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
488 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
489 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
490 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
491 1YNL 1 L Ig gamma light chain 10090
492 1YNL 2 H Ig gamma heavy chain 10090
493 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
494 5EPM 2 B, F Antibody Fab fragment light chain 10090
495 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
496 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
497 3UMT 1 A scFv heavy chain and light chain 10090
498 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
499 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
500 4NUJ 1 A PGT152 light chain 9606
501 4NUJ 2 B PGT152 heavy chain 9606
502 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
503 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
504 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
505 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
506 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
507 3U2S 2 B, L PG9 light chain 9606
508 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
509 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
510 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
511 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
512 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
513 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
514 4NUG 1 L PGT151 light chain 9606
515 4NUG 2 H PGT151 heavy chain 9606
516 3IU4 1 H chP3 Fab heavy chain 10090
517 3IU4 2 L chP3 Fab light chain 10090
518 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
519 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
520 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
521 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
522 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
523 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
524 1P7K 1 A, L antibody light chain FAB 10090
525 1P7K 2 B, H antibody heavy chain FAB 10090
526 3RVV 2 C 4C1 - light chain 10090
527 3RVV 3 D 4C1 - heavy chain 10090
528 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
529 3P0Y 2 H Fab DL11 heavy chain 9606
530 3P0Y 3 L Fab DL11 light chain 9606
531 4NPY 1 A, L germline PGT121 light chain Fab 9606
532 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
533 6ANA 2 H LL2 Fab Heavy Chain 10090
534 6ANA 3 L LL2 Fab Light Chain 10090
535 5IBU 1 B, L 6652 Light Chain 9606
536 5IBU 2 G, H 6652 Heavy Chain 9606
537 5VPL 2 C 4C1 - LIGHT CHAIN 10090
538 5VPL 3 D 4C1 - HEAVY CHAIN 10090
539 6AOD 1 A FXIa Antibody FAB Light Chain 9606
540 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
541 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
542 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
543 2YPV 2 H FAB 12C1 10090
544 2YPV 3 L FAB 12C1 10090
545 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
546 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
547 4JY5 1 L PGT122 light chain Fab 9606
548 4JY5 2 H PGT122 heavy chain Fab 9606
549 6ELE 1 A, H fAB heavy chain 9606
550 6ELE 2 B, L fAB light chain 9606
551 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
552 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
553 6B5R 1 H CIS42 Fab Heavy chain 9606
554 6B5R 2 L CIS42 Fab Light chain 9606
555 3NAC 1 L Fab15 Mut7 light chain 9606
556 3NAC 2 H Fab15 Mut7 heavy chain 9606
557 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
558 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
559 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
560 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
561 1Q72 1 L Fab M82G2, Light chain 10090
562 1Q72 2 H Fab M82G2, Heavy chain 10090
563 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
564 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
565 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
566 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
567 4YHO 1 H aDabi-Fab3 heavy chain 9606
568 4YHO 2 L aDabi-Fab3 light chain 9606
569 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
570 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
571 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
572 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
573 4DGY 1 H HCV1 Heavy Chain Fab 9606
574 4DGY 2 L HCV1 Light Chain 9606
575 5EN2 1 A GD01 heavy chain 10090
576 5EN2 2 B GD01 light chain 10090
577 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
578 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
579 3MXW 2 L 5E1 light chain 9606
580 3MXW 3 H 5E1 heavy chain 9606
581 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
582 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
583 3EO9 1 L Efalizumab Fab fragment, light chain 9606
584 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
585 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
586 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
587 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
588 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
589 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
590 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
591 5WUV 1 L light chain 9606
592 5WUV 2 H heavy chain 9606
593 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
594 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
595 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
596 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
597 4JM4 1 H PGT 135 Heavy Chain Fab 9606
598 4JM4 2 L PGT 135 Light Chain Fab 9606
599 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
600 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
601 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
602 5YE4 2 B, D 1A9D7 L chain 10090
603 6B0G 1 C 1245 Antibody, Light Chain 9606
604 6B0G 2 D 1245 Antibody, Heavy Chain 9606
605 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
606 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
607 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
608 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
609 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
610 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
611 6D0X 1 A 2140 Antibody, heavy chain 9606
612 6D0X 2 B 1210 Antibody, light chain 9606
613 6BE4 1 H Fab (F598) Heavy Chain 9606
614 6BE4 2 L Fab(F598) Light Chain 9606
615 5TPP 1 L DH270.5 Fab heavy chain 9606
616 5TPP 2 H DH270.5 Fab light chain 9606
617 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
618 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
619 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
620 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
621 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
622 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
623 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
624 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
625 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
626 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
627 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
628 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
629 5TL5 1 L M2177 LIGHT CHAIN 10090
630 5TL5 2 H M2177 HEAVY CHAIN 10090
631 2FX7 1 L Fab 4E10 Light Chain 9606
632 2FX7 2 H Fab 4E10 Heavy Chain 9606
633 5Y9K 1 L belimumab light chain 9606
634 5Y9K 2 H belimumab heavy chain 9606
635 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
636 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
637 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
638 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
639 3WFH 1 A mAb Fab H fragment 10090
640 3WFH 2 B mAb Fab L fragment 10090
641 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
642 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
643 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
644 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
645 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
646 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
647 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
648 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
649 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
650 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
651 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
652 5HI4 3 D, L CAT-2000 FAB light chain 9606
653 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
654 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
655 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
656 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
657 3RVW 2 C 4C1 - light chain 10090
658 3RVW 3 D 4C1 - heavy chain 10090
659 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
660 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
661 5XKU 2 B HNIgGA6 light chain 9606
662 5XKU 3 C HNIgGA6 heavy chain 9606
663 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
664 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
665 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
666 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
667 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
668 5HI5 3 D, L CAT-2000 light chain 9606
669 5JO5 1 A, C, E, H 10E8 gHV 9606
670 5JO5 2 B, D, F, L 10E8 gLV 9606
671 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
672 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
673 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
674 5CCK 2 L Antibody 3BC315 Fab light chain 9606
675 5I76 1 A, C FM318_light_chain 1383439
676 5I76 2 B, D FM318_heavy_cahin 1383439
677 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
678 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
679 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
680 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
681 5I18 1 L FAB LIGHT CHAIN 9606
682 5I18 2 H FAB HEAVY CHAIN 9606
683 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
684 4JN1 2 L anti-dabigatran Fab1, light chain 10090
685 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
686 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
687 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
688 4G5Z 2 L canakinumab antibody fragment light chain 9606
689 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
690 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
691 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
692 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
693 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
694 2OK0 2 L Fab ED10 light chain 10090
695 2OK0 3 H Fab ED10 heavy chain 10090
696 3SOB 1 L antibody light chain 9606
697 3SOB 3 H antibody heavy chain 9606
698 6B5M 1 H CIS43 Fab Heavy chain 9606
699 6B5M 2 L CIS43 Fab Light chain 9606
700 5AWN 1 H Heavy chain of 3BC176 Fab 9606
701 5AWN 2 L Light chain of 3BC176 Fab 9606
702 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
703 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
704 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
705 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
706 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
707 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
708 5DR5 2 L AbD09097 Fab light chain 9606
709 2IH3 1 A FAB Heavy Chain 10090
710 2IH3 2 B FAB Light Chain 10090
711 4KQ3 1 L CNTO3186 light chain Fab 9606
712 4KQ3 2 H CNTO3186 heavy chain Fab 9606
713 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
714 6AQ7 3 L POM6 FAB light CHAIN 10090
715 4JFX 1 A, L Fab light chain 9606
716 4JFX 2 B, H Fab heavy chain 9606
717 3SGE 1 I, L Light Chain 10090
718 3SGE 2 H, J Heavy Chain 10090
719 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
720 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
721 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
722 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
723 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
724 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
725 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
726 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
727 5FHB 1 H Antibody 100 Fab heavy chain 9606
728 5FHB 2 L Antibody 100 Fab light chain 9606
729 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
730 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
731 1JGU 1 L Antibody Light Chain 10090
732 1JGU 2 H Antibody Heavy Chain 10090
733 4I77 1 H Lebrikizumab heavy chain Fab 9606
734 4I77 2 L Lebrikizumab light chain Fab 9606
735 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
736 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
737 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
738 4O4Y 2 H 2095-2 heavy chain 9986
739 5OBF 1 H fAb Heavy chain 10090
740 5OBF 2 L fAb Light chain 10090
741 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
742 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
743 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
744 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
745 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
746 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
747 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
748 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
749 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
750 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
751 5MHE 1 L Fab-fragment 10090
752 5MHE 2 H Fab-fragment 10090
753 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
754 4GLR 3 I, K anti-ptau light chain light chain 9031
755 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
756 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
757 4HJG 1 A Trastuzumab light chain 9606
758 4HJG 2 B Trastuzumab heavy chain 9606
759 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
760 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
761 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
762 5I30 1 L Fab PL-2 light chain 10090
763 5I30 2 H Fab PL-2 heavy chain 10090
764 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
765 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
766 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
767 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
768 3FN0 1 L Fab Z13e1 light chain 9606
769 3FN0 2 H Fab Z13e1 heavy chain 9606
770 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
771 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
772 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
773 4YHI 2 B, L aDabi-Fab2a light chain 9606
774 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
775 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
776 4OSU 1 H SM5-1 Fab Heavy Chain 9606
777 4OSU 2 L SM5-1 Fab Light Chain 9606
778 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
779 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
780 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
781 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
782 1T2Q 1 L Fab NNA7 Heavy Chain 10090
783 1T2Q 2 H Fab NNA7 Light Chain 10090
784 6ELJ 1 A, H fAB heavy chain 9606
785 6ELJ 2 B, L fAB light chain 9606
786 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
787 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
788 4MAU 1 L C2244 light chain SEE REMARK 999 10090
789 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
790 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
791 3LEX 2 B, L 11f10 Antibody Light Chain 10090
792 6B0W 1 L 1710 antibody, light chain 9606
793 6B0W 2 H 1710 antibody, heavy chain 9606
794 1OP3 1 K, L FAB 2G12, light chain light chain 9606
795 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
796 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
797 5VH4 2 B, L Infliximab Fab Light Chain 10090
798 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
799 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
800 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
801 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
802 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
803 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
804 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
805 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
806 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
807 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
808 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
809 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
810 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
811 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
812 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
813 3S96 1 A, C 3B5H10 FAB heavy chain 10090
814 3S96 2 B, D 3B5H10 FAB light chain 10090
815 4LKX 1 A Fab fragment heavy chain 9606
816 4LKX 2 B Fab fragment light chain 9606
817 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
818 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
819 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
820 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
821 5JW5 1 A, H MEDI8852 Heavy chain 9606
822 5JW5 2 B, L MEDI8852 Light chain 9606
823 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
824 5VH3 2 B, L Infliximab Fab Light Chain 10090
825 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
826 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
827 5HDQ 2 H Fab Heavy Chain 10090
828 5HDQ 3 L Fab Light Chain 10090
829 4FQ2 1 H Fab heavy chain 9606
830 4FQ2 2 L Fab light chain 9606
831 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
832 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
833 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
834 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
835 2A77 1 L Immunoglobulin Light Chain 10090
836 2A77 2 H Immunoglobulin Heavy Chain 10090
837 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
838 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
839 3GO1 1 L Fab 268-D, light chain 9606
840 3GO1 2 H Fab 268-D, heavy chain 9606
841 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
842 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
843 3QWO 1 B, L motavizumab light chain 10090
844 3QWO 2 A, H motavizumab heavy chain 10090
845 3CVI 1 H 25-D1.16 Heavy chain 10090
846 3CVI 2 L 25-D1.16 Light chain 10090
847 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
848 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
849 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
850 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
851 4IOI 1 A Trastuzumab light chain 9606
852 4IOI 2 B Trastuzumab heavy chain 9606
853 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
854 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
855 4OKV 1 A, C heavy chain of 8H7 mAb 10090
856 4OKV 2 B, D light chain of 8H7 mAb 10090
857 6GHG 1 A, H Fab heavy chain 9606
858 6GHG 2 B, L Fab light chain 9606
859 6B5S 1 H CIS42 Fab Heavy chain 9606
860 6B5S 2 L CIS42 Fab Light chain 9606
861 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
862 5K8A 2 B, F, H, V Heavy chain 10090
863 5WKZ 1 H Immunoglobulin heavy variable 1-69D,IgG H chain 9606
864 5WKZ 2 L Lambda-chain (AA -20 to 215) 9606
865 1JGV 1 L Antibody Light Chain 10090
866 1JGV 2 H Antibody Heavy Chain 10090
867 5VAG 2 B Light chain of antibody m826 9606
868 5VAG 3 C Heavy chain of antibody m826 9606
869 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
870 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
871 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
872 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
873 5GIR 1 A, H Heavy chain of Fab fragment 10090
874 5GIR 2 B, L Light chain of Fab fragment 10090
875 2ADF 2 H 82D6A3 IgG FAB 10090
876 2ADF 3 L 82D6A3 IgG FAB 10090
877 5I16 1 A, L FAB LIGHT CHAIN 9606
878 5I16 2 B, H FAB HEAVY CHAIN 9606
879 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
880 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
881 5F9O 2 H CH235.9 Heavy chain 9606
882 5F9O 3 L CH235.09 Light chain 9606
883 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
884 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
885 1UM4 1 L Antibody 21H3 L chain 10090
886 1UM4 2 H Antibody 21H3 H chain 10090
887 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
888 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
889 4RBP 1 K, L Fab 2G12 light chain 9606
890 4RBP 2 H, M Fab 2G12 heavy chain 9606
891 3I75 1 A Antibody heavy chain 10090
892 3I75 2 B Antibody light chain 10090
893 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
894 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
895 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
896 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
897 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
898 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
899 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
900 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
901 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
902 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
903 5GIS 1 H Heavy chain of Fab fragment 10090
904 5GIS 2 L Light chain of Fab fragment 10090
905 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
906 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
907 6B0S 1 H 1710 antibody, heavy chain 9606
908 6B0S 2 L 1710 antibody, light chain 9606
909 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
910 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
911 5GRX 1 G, H diabody protein 9606
912 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
913 6DCW 2 H Heavy chain of CBTAU27.1 Fab 9606
914 6DB6 1 H Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab heavy chain 9606
915 6DB6 2 L Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab light chain 9606
916 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
917 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
918 5GGQ 1 L nivolumab light chain 9606
919 5GGQ 2 H nivolumab heavy chain 9606
920 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
921 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
922 6B5N 1 H CIS43 Fab Heavy chain 9606
923 6B5N 2 L CIS43 Fab Light chain 9606
924 3OAY 1 K, L Fab 2G12, light chain 9606
925 3OAY 2 H, M Fab 2G12, heavy chain 9606
926 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
927 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
928 6AND 2 H Pinatuzumab Fab Heavy chain 9606
929 6AND 3 L Pinatuzumab Fab light chain 9606
930 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
931 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
932 5W0D 2 B Lineage K03.12 UCA antibody heavy chain 9606
933 5W0D 3 C Lineage K03.12 UCA antibody light chain 9606
934 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
935 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090
936 4GMT 1 L, M Fab S139/1 light chain 10090
937 4GMT 2 H, I Fab S139/1 heavy chain 10090
938 6BPB 1 A Monoclonal antibody 4F7 Fab heavy chain 10090
939 6BPB 2 B Monoclonal antibody 4F7 Fab light chain 10090
940 5K9J 1 H 56.a.09 heavy chain 9606
941 5K9J 2 L 56.a.09 light chain 9606
942 5DS8 1 A, H Fab Hpu98 Heavy Chain 9986
943 5DS8 2 B, L Fab Hou98 Light Chain 9986
944 3ZKM 2 C, H FAB HEAVY CHAIN 9606
945 3ZKM 3 D, L FAB LIGHT CHAIN 10090
946 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN